Company
TagCyx Biotechnologies, Inc.,
Developing innovative therapeutics and medical devices using Xenoligo aptamers, focused on safe therapies for women.
- Status
- Operatingas of 2026-09-23
- Business model
- B2B
- Headquarters
- Meguro, Tokyo, Japan
- Legal name
- タグシクス・バイオ株式会社
Claim, correct or request removal
Record updated 28 September 2026
About
Using its proprietary artificial nucleic acid molecules and base-pairing technology, TAGCyx Biotech's mission is to provide new therapies to the world of medicine. While developing innovative therapeutics and medical devices that take advantage of the characteristics of Xenoligo® aptamers, we will focus on developing safe treatments for women. We aim to be a company that grows by valuing our world-class proprietary technology and team strength, as well as partnerships with partner companies.
Loading relationship preview